Barclays Maintains Equal-Weight on Humana, Raises Price Target to $253
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Equal-Weight rating on Humana and raises the price target from $250 to $253.
October 31, 2024 | 6:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Andrew Mok maintains an Equal-Weight rating on Humana and raises the price target from $250 to $253.
The increase in the price target from $250 to $253 by Barclays suggests a slightly more positive outlook on Humana's stock, which could lead to a minor positive impact on the stock price. However, the Equal-Weight rating indicates a neutral stance, balancing the impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100